Audited Results of Ajanta Pharma Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	4,845.92	4,322.04	3,971.12	3,411.27	3,140.64
Manufacturing Expenses	73.17	70.22	66.44	65.53	54.09
Personnel Expenses	1,194.05	1,010.90	834.16	720.41	585.87
Selling Expenses	0.65	5.76	4.49	5.02	4.78
Administrative Expenses	1,238.86	962.03	818.43	849.29	718
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	3,647.93	3,117.32	2,851.69	2,711.99	2,249.75
Operating Profit	1,197.99	1,204.72	1,119.43	699.28	890.89
Other Recurring Income	204.40	119.87	116.48	132.75	139.73
Adjusted PBDIT	1,402.39	1,324.59	1,235.91	832.03	1,030.62
Financial Expenses	2.59	4.60	6.80	5.23	9.12
Depreciation	168.77	139.93	132.16	126.95	120.96
Other Write offs	0	0	0	0	0
Adjusted PBT	1,231.03	1,180.06	1,096.95	699.85	900.54
Tax Charges	284.21	263.17	289.71	141.13	180.68
Adjusted PAT	946.82	916.89	807.24	558.72	719.86
Non Recurring Items	0	0	0	0	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	946.82	916.89	807.24	558.72	719.86
Equity Dividend	349.82	349.75	642.17	89.69	82.21
Preference Dividend	0	0	0	0	0
Retained Earnings	4,204.47	3,820.58	3,254.36	3,164.01	2,763.48

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article